CPC A61K 35/19 (2013.01) [A61K 9/0085 (2013.01); A61P 25/28 (2018.01); C12N 5/0644 (2013.01)] | 13 Claims |
1. A method for treatment of a neurological disorder, comprising the step of administering a heat-treated pooled human platelet lysate to a patient or subject in need thereof, wherein the heat-treated pooled human platelet lysate has a fibrinogen content of less than 5% by weight of the fibrinogen content of non-heat-treated pHPL and a fibrinogen content of less than 50 ng/mL.
|